---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-031713"
form_type: "8-K"
ticker: "VCEL"
cik: "0000887359"
company_name: "Vericel Corp"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:22:11.758246+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vericel Q1 revenue up 30% to $68.4M, net loss narrows; raises FY revenue guidance to $326-336M

## Summary
- Total revenue up 30% to $68.4M; MACI revenue up 22% to $56.4M, Burn Care up 91% to $12.0M.
- Net loss narrowed to $6.3M from $11.2M; adjusted EBITDA up 195% to $9.6M (14% of revenue).
- Raised full-year 2026 revenue guidance by $10M to $326-336M; reaffirmed ~75% gross margin and ~27% adjusted EBITDA margin.
- Free cash flow of $15.1M; cash and investments $211M, no debt.
- Received FDA approval for MACI commercial manufacturing at new facility; BARDA award up to $197M for NexoBrid.

## SEC filing metadata
- accession: 0001628280-26-031713
- form_type: 8-K
- ticker: VCEL
- cik: 0000887359
- company_name: Vericel Corp
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887359/000162828026031713/0001628280-26-031713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887359/000162828026031713/vcel-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-031713
- JSON: https://secwatch.observer/filing/0001628280-26-031713.json
- Plain text: https://secwatch.observer/filing/0001628280-26-031713.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.